Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Compare three bowel-cleansing methods before colonoscopy: 4-L PEG with bisacodyl and docusate, 2-L PEG with simethicone, and 2-L PEG alone.

Official title: Comparative Study Between Using a 4-L Split-dose Polyethylene Glycol and Bisacodyl + Docusate Sodium Regimen Versus a 2-L Split-dose Polyethylene Glycol Plus Oral Simethicone Regimen Versus Conventional Method for Bowel Preparation Before Colonoscopy

Run by Tanta University · NCT07328880 · Data updated 2026-11-12

This test compares three bowel-cleansing methods to see which is safest, easiest to tolerate, and cleans best for adults preparing for a colonoscopy.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment450 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbyea)
StatusRecruiting
StartedApril 1, 2025
Main results expectedApril 1, 2026
Study endsApril 26, 2026
Registry record updatedJanuary 9, 2026
Trial IDNCT07328880 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 scheduled for an outpatient colonoscopy who can give written informed consent are the ideal candidates.

Probably not a fit

Patients with renal failure, cirrhosis or ascites, congestive heart failure, bleeding disorders, seizure disorder, gastrointestinal obstruction or perforation, pregnancy or lactation, or known allergy to the preparations are excluded and would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial at Tanta University Hospitals enrolls adults aged 18–70 undergoing outpatient colonoscopy and assigns them to one of three bowel-preparation regimens: 4-L split-dose polyethylene glycol with bisacodyl and docusate sodium, 2-L split-dose polyethylene glycol plus oral simethicone, or 2-L split-dose polyethylene glycol alone. Participants will have history-taking, clinical examination, laboratory tests, and a colonoscopy performed 24 hours after starting the preparation. Bowel cleanliness will be rated using the Aronchick bowel preparation scale, and investigators will record adverse events and patient compliance. The trial directly compares safety, tolerability, and cleansing effectiveness across the three regimens.

Why it matters

Potential benefit: If successful, the best regimen could provide better bowel cleanliness with fewer side effects, making colonoscopies quicker and more accurate.

How similar studies have gone: Similar reduced-volume PEG regimens with adjuncts such as bisacodyl or simethicone have shown mixed but generally promising results for improving tolerability and bowel cleanliness in prior trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing colonoscopy as a day-care procedure for various indications (lower GI bleeding, colorectal cancer screening, altered bowel habits, etc.)
* Patients of either sex aged \>18 years and \<70 years.
* Patients willing to give written informed consent.

Exclusion Criteria:

* Presence of Renal failure, cirrhosis, ascites, CCF, bleeding disorders, seizure disorder, gastrointestinal obstruction, or perforation.
* History of serious adverse events to other electrolyte-based colonic lavages.
* Female patients who are pregnant or lactating or considering pregnancy.
* Allergy.

Where it's running

  • Tanta University Hospitals
    Tanta, Gharbyea, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.